REGN-5093-M114

N/A

Report date: 2025/11/04 20:00:06

Base Information

Drug NameREGN-5093-M114

Drug Alias NameMETxMET-M114REGN5093-M114

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > M24 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionHepatocyte growth factor receptor inhibitorsApoptosis stimulantsTubulin polymerisation inhibitors

TargetsHepatocyte growth factor receptorTubulin

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesRegeneron Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRegeneron Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A